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vessel, bronchus, or interlobar space. When a silicone tube guide
is used, the vessel, bronchus, or lung tissue is stapled while
keeping the guide attached (Figure 2). When the Penrose drain is
used, we remove the drain from the tip of the endostapler and then
staple the tissue.
Results
There was no misfire or accidental injury of vessels or surrounding
tissues in the use of the endostapler. The time between dissecting
the vessels and the end of stapling with the silicone tube guide was
significantly shorter than that with the Penrose drain (mean  SE:
silicone tube, 191 25 seconds; Penrose drain, 392 94 seconds;
P  .01).
Discussion
Mechanical stapling for vessels and bronchus is a safe method,
especially in video-assisted thoracoscopic lung lobectomy. A Pen-
rose drain has been used as a guide for the endostapler. However,
it must be detached from the jaw of the endostapler before stapling
near the hilum of the lung in the thoracic cavity. The elasticity of
the Penrose drain is so soft that it occasionally fails to lead the
endostapler behind the vessel.
The silicone tube guide is so small that we can pass the
11-mm port as it is attached to the jaw, and therefore the
attachment on the jaw can be made out of the body. In addition,
an endostapler can be attached to either side of the silicone
guide. It has elasticity appropriate for guiding the tip of the
endostapler. The biggest advantage of this guide is that stapling
can be done with the guide attached. We can control the
position of the tip of the endostapler at the time of stapling with
the silicone tube. It simplifies intrathoracic manipulation and
eliminates the possibility of injuring other vessels or lung tissue
with the jaw. It also saves operating time.
Conclusions
The use of a soft silicone tube guide can improve the safety of lung
lobectomy with automatic suture devices and shorten the operative
time.
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Mitral valve reconstruction in a compound
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Sickle cell disease presents a multitude of challenges inpatients undergoing cardiac operations. In these pa-tients, cardiopulmonary bypass (CPB) may trigger acrisis of profound magnitude. The prevention of sick-
ling of red blood cells and its sequelae of hemolysis and
vaso-occlusive crises
during CPB is
achieved primarily by
reducing the level of
hemoglobin S before
operation.1,2
Hemoglobin Lepore (2[]2) is a hemoglobin variant with
a  chain that is a result of fusion of a  and a  globin gene.
The hybrid gene is expressed at a roughly intermediate level,
between the  and the  globin genes. The phenotype of the
heterozygote thus closely resembles the classical thalassemia
trait. To date, only 20 cases of compound heterozygotes with
hemoglobin Lepore/hemoglobin S have been reported, and they
are characterized by hematologic as well as clinical heteroge-
neity. The hemoglobin S/hemoglobin Lepore combination may
have enough hemoglobin S to cause serious sickling, particu-
larly if an excess of  chains were to have harmful conse-
quences, as has been asserted.3 We report a case of mitral valve
reconstruction performed safely in a compound heterozygote
for sickle cell anemia and hemoglobin Lepore.
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Clinical Summary
A 26-year-old Greek man, compound heterozygote for sickle cell
anemia and hemoglobin Lepore, came to our department with
symptoms of progressive dyspnea and fatigue. His medical history
was significant for several hospital admissions for sickling crises,
one of which had necessitated blood transfusions.
On physical examination, the patient had a blood pressure of
100/70 mm Hg, a pulse of 90 beats/min, and a respiratory rate of
16 breaths/min. The heart had a regular rhythm, with a 3/6 apical
holosystolic murmur radiating to the axilla. Further evaluation,
including transesophageal echocardiography, disclosed severe mi-
tral regurgitation, with prolapse of the anterior mitral valve leaflet,
accompanied by annular dilatation and significant left atrial and
left ventricular enlargement. Left ventricular internal dimensions
during diastole and systole were 68 mm and 54 mm, respectively.
Catheterization demonstrated a pulmonary artery pressure of 45/21
mm Hg and a left ventricular end-diastolic pressure of 22 mm Hg.
The ventriculogram noted global hypokinesis, with an ejection
fraction of 0.43. Coronary angiography showed no abnormalities.
The patient was referred for mitral valve repair.
Approximately 1 week before the operation, the patient under-
went therapeutic phlebotomy and exchange transfusion with
leukocyte-depleted, phenotypically matched packed erythrocytes
to decrease the level of hemoglobin S. Hemoglobin and hematocrit
at that time were 10.2 g/dL and 33.2%, respectively. Hemoglobin
electrophoresis demonstrated 77.5% hemoglobin S. After the ex-
change transfusion, hemoglobin and hematocrit remained stable,
but hemoglobin S was only 44.5%.
The procedure was carried out with normothermic (37°C) CPB.
After crossclamping of the aorta, intermittent, antegrade, hy-
perkalemic warm blood cardioplegia supplemented with magne-
sium was administered in the aortic root.4 The mitral valve was
approached through the superior septal approach. It was found to
be a Barlow type of valve, with annular dilatation and excess tissue
in both mitral leaflets. It was repaired with a flexible mitral ring
(size 36 mm Annuloflex; Sulzer Carbomedics Inc, Austin, Tex).
Aortic crossclamp time was 32 minutes. Intraoperative transesoph-
ageal echocardiography showed no residual mitral regurgitation.
The patient had an uneventful postoperative recovery. He was
discharged from the hospital on the sixth postoperative day.
Discussion
The absolute safe level of hemoglobin S during operations with
CPB has not been clearly defined. A growing body of evidence
suggests that limited dilution of sickle cells is beneficial. In a
pivotal study, a preoperative hemoglobin S level of 30% or less
allowed elective surgery to be performed safely in patients with
sickle cell disease; these values may represent a suitable aim for
patients undergoing CPB.5 Hemoglobin S reduction can be
achieved by simple transfusion for several weeks preoperatively,
partial exchange transfusion in the preoperative period, complete
exchange transfusion with the CPB circuit, or a combination of
these techniques.1,2 Preoperative exchange transfusion increases the
percentage of hemoglobin A relative to that of hemoglobin S and,
more importantly, suppresses further production of hemoglobin S.
During an operation, predisposing factors that elicit sickling (includ-
ing hypoxia, low-flow states, hypovolemia, acidosis and hypothermia)
should be avoided.1,2 Hypothermia can cause vasoconstriction and slug-
ging of red cells and therefore potentially increase capillary transit time
and the risk of sickling of red cells. In view of this potential complication
of hypothermia, we aimed to perform warm heart surgery with normo-
thermic CPB of the minimum duration.
In conclusion, preoperative exchange transfusion enabled us to
perform mitral valve repair uneventfully in a compound heterozy-
gote for sickle cell anemia and hemoglobin Lepore.
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